Table 3.
Group | RFLP 1 | RFLP Transitional | RFLP 2 |
---|---|---|---|
Co-infection trial | |||
1 | 37/37 | 0/37 | 0/37 |
2 | 8/18 | 2/18 | 8/18 |
3 | 0/24 | 0/24 | 24/24 |
Dose titration and route of challenge trial | |||
A | 2/35 | 1/35 | 32/35 |
B | 5/30 | 2/30 | 23/30 |
C | 18/40 | 6/40 | 16/40 |
D | 19/35 | 2/35 | 14/35 |